Drug Profile
LHA 510
Alternative Names: LHA-510Latest Information Update: 15 Apr 2019
Price :
$50
*
At a glance
- Originator Alcon
- Class Eye disorder therapies
- Mechanism of Action Vascular endothelial growth factors inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Wet age-related macular degeneration